Pharmacotherapy, Volume 14Pharmacotherapy Publications, 1994 - Chemotherapy |
Contents
Summary of Phase I Trials With Paclitaxel continued | 12 |
MDA61 80 | 21 |
JHOC78 Various | 33 |
Copyright | |
21 other sections not shown
Other editions - View all
Common terms and phrases
abstr acetaminophen acid activity administration adverse effects agents alcohol analgesic analysis antibiotic antihypertensive antimicrobial assay assessment associated bactericidal baseline blood pressure Bromfenac cancer cardiac Cardiol cells cimetidine ciprofloxacin clearance clinical pharmacy clinical trials codeine combination compared correlation cortisol cyclosporine decreased depression determined diastolic differences diltiazem disease dosage dose double-blind efficacy evaluated fluoxetine fosphenytoin frequency function gentamicin hospital hypertension hypertensive patients increased infections infusion inhibitors intravenous ketorolac left ventricular hypertrophy LV mass LVMI lymphocyte mean measured Medical metabolism method methylprednisolone mg/day mg/m² monitoring myocardial oral paclitaxel pain intensity pain relief paroxetine patients receiving Ph.D Pharm Pharm.D pharmacists pharmacokinetics Pharmacotherapy phase phenytoin picenadol piperacillin placebo plasma pulmonary ranitidine reactions receptor reduction regimens regression renal reported response risperidone samples score serum concentrations significant significantly statistically subjects symptoms systolic Taxol teicoplanin therapeutic toxicity transplant treatment vancomycin verapamil vitro weeks µg/ml